Picture of Kenvue logo

KVUE — Kenvue News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesBalancedLarge CapSuper Stock

Kenvue Q3 sales slightly beat expectations on self care segment growth

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
    
Overview
    * Consumer health products maker's fiscal Q3 sales rose 3.2%, slightly beating analyst expectations
    * Adjusted diluted EPS for fiscal Q3 rose 4% to $0.29
    * Company cites margin expansion and productivity gains as drivers of quarterly results

    
Outlook
    * Kenvue will not provide forward-looking guidance due to the pending Kimberly-Clark transaction

    
Result Drivers
    * SELF CARE SEGMENT - Co said Self Care segment drove growth, with net sales up 5.9% on strong demand for smoking cessation and pain care products, innovation, and commercial execution
    * PRODUCTIVITY INITIATIVES - Co attributed margin expansion to productivity gains from global supply chain optimization, U.S. tariff refunds, and favorable value realization, partially offset by inflation and unfavorable transactional FX
    * RESTRUCTURING INITIATIVE - Co said cost optimization actions, including the 2026 Restructuring Initiative and Vue Forward, contributed to improved operating income margin, partially offset by increased brand support

    
Company press release:  ID:nBwc383Pla 
    
Key Details
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
 Q3 Sales  Slight    $3.89     $3.86
           Beat*     bln       bln (10
                               Analysts
                               )
 Q3                  $0.29      
 Adjusted                      
 EPS                           
 Q3 EPS              $0.22      
 Q3 Net              $430 mln   
 Income                        
 Q3 Gross            $2.31      
 Profit              bln       
 Q3                  $706 mln   
 Operatin                      
 g Income                      
 Q3                  $609 mln   
 Pretax                        
 Profit                        
    *Applies to a deviation of less than 1%; not applicable for per-share numbers.
    
Analyst Coverage
    * The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 13 "hold" and no "sell" or "strong sell"
    * The average consensus recommendation for the personal products peer group is "buy."
    * Wall Street's median 12-month price target for Kenvue Inc. is $19.00, about 2.9% below its October 29 closing price of $19.56
    * The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 16 three months ago

    
Reuters Recommended Reads
    * Oct 27 - Coca-Cola lifts profit forecast on international soda demand, flags higher costs
    * Oct 27 - Rocky Brands Q3 sales rise on strong demand, tariff refund helps margins
    * Oct 28 - Food and household brands warn of more price hikes as Iran war costs bite

    
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

    (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Kenvue

See all news